ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,506Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 676

$920K Total Retail Price of All Prescriptions

Rank: 76 out of 676

862 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 862 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

6% of this provider’s 862 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 14,937 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
LISINOPRIL 970 772 1 5
SIMVASTATIN 800 713 2 6
OMEPRAZOLE 654 520 3 2
LOVASTATIN 508 463 4 33
AMLODIPINE BESYLATE 498 387 5 3
ZOLPIDEM TARTRATE 490 378 6 21
PRAVASTATIN SODIUM 487 438 7 11
LEVOTHYROXINE SODIUM 486 363 8 7
METFORMIN HCL 480 376 9 8
GABAPENTIN 411 276 10 10
CARVEDILOL 381 319 11 15
CITALOPRAM HBR 341 269 12 17
FUROSEMIDE 312 261 13 4
WARFARIN SODIUM 297 233 14 18
METOPROLOL TARTRATE 263 187 15 22
LOSARTAN POTASSIUM 252 230 16 34
FENOFIBRATE 246 221 17 90
METOPROLOL SUCCINATE 239 215 18 14
HYDROCHLOROTHIAZIDE 237 203 19 12
TRIAMTERENE-HCTZ 223 180 20 43
SERTRALINE HCL 215 147 21 26
CRESTOR 214 167 22 29
RANITIDINE HCL 213 119 23 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 205 174 24 16
TAMSULOSIN HCL 195 173 25 38
POTASSIUM CHLORIDE 186 177 26 9
GLIMEPIRIDE 174 152 27 30
ALLOPURINOL 172 163 28 31
TRAMADOL HCL 169 132 29 19
AMITRIPTYLINE HCL 167 106 R 30 46
ATORVASTATIN CALCIUM 162 141 31 20
CYMBALTA 157 102 32 47
MELOXICAM 153 107 33 13
NEXIUM 152 127 34 23
ATENOLOL 144 106 35 25
HYDROCODONE-ACETAMINOPHEN 143 110 S3 36 1
LOSARTAN-HYDROCHLOROTHIAZIDE 139 116 37 51
TIZANIDINE HCL 137 75 38 68
TRAZODONE HCL 132 69 39 36
FLUTICASONE PROPIONATE 128 97 40 49
DILTIAZEM 24HR CD 126 126 41 152
PAROXETINE HCL 120 60 42 65
CLONIDINE HCL 117 106 43 32
LYRICA 114 82 44 57
VERAPAMIL ER 109 71 45 101
DONEPEZIL HCL 106 78 46 24
PROPRANOLOL HCL 105 84 47 120
CLOPIDOGREL 99 91 48 28
ALENDRONATE SODIUM 97 76 49 61
SINGULAIR 95 64 50 80
SYNTHROID 93 69 51 48
GLYBURIDE-METFORMIN HCL 93 93 R 51 76
NAMENDA 92 92 53 35
FLUOXETINE HCL 91 64 54 70
PLAVIX 91 76 54 40
DICLOFENAC SODIUM 90 79 56 142
DIOVAN 88 76 57 37
DIGOXIN 86 83 58 52
AMLODIPINE BESYLATE-BENAZEPRIL 84 79 59 44
BYSTOLIC 81 80 60 96
PHENYTOIN SODIUM EXTENDED 74 31 61 88
PROAIR HFA 73 33 62 79
DOXAZOSIN MESYLATE 72 66 63 116
POLYETHYLENE GLYCOL 3350 72 51 63 56
ZETIA 69 57 65 89
DICYCLOMINE HCL 68 32 66 207
CIPROFLOXACIN HCL 66 55 67 45
MONTELUKAST SODIUM 65 44 68 150
DILTIAZEM ER 64 43 69 118
BENAZEPRIL HCL 64 60 69 58
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 49 71 140
DIOVAN HCT 63 57 71 41
BENZTROPINE MESYLATE 62 0 R 73 129
GEMFIBROZIL 59 46 74 137
VYTORIN 57 44 75 176
VENLAFAXINE HCL ER 57 27 75 98
ESCITALOPRAM OXALATE 54 54 77 73
ENALAPRIL MALEATE 53 38 78 65
SPIRONOLACTONE 53 37 78 62
AZITHROMYCIN 51 40 80 39
RISPERIDONE 50 12 81 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.